BMJ Group: Further Evidence of Developmental Risks Linked to Epilepsy Drugs in Pregnancy
March 12, 2026
March 12, 2026
LONDON, England, March 12 (TNSjou) -- BMJ Group issued the following news release about The BMJ:
* * *
Further evidence of developmental risks linked to epilepsy drugs in pregnancy
Study adds weight to previously reported risks and calls for monitoring of new antiseizure drugs
*
Findings (https://www.bmj.com/content/392/bmj-2025-085725) published by The BMJ today reinforce previous research linking use of the antiseizure drug valpr . . .
* * *
Further evidence of developmental risks linked to epilepsy drugs in pregnancy
Study adds weight to previously reported risks and calls for monitoring of new antiseizure drugs
*
Findings (https://www.bmj.com/content/392/bmj-2025-085725) published by The BMJ today reinforce previous research linking use of the antiseizure drug valpr . . .